The Risk GP Model: The standard model of prediction in medicine

Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical Sciences

Volumn 54, Issue , 2015, Pages 49-61

  Fuller, Jonathan ^a   Flores, Luis J ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Epidemiology; Extrapolation; Medicine; Prediction; Probability; Risk

Indexed keywords

EPIDEMIOLOGY; HUMAN; PUBLIC HEALTH; RISK; THEORETICAL MODEL;

EPIDEMIOLOGIC METHODS; HUMANS; MODELS, THEORETICAL; PUBLIC HEALTH; RISK;

EID: 84947019347     PISSN: 13698486     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.shpsc.2015.06.006     Document Type: Article

References (70)

1. Andersen H. Mechanisms: What are they evidence for in evidence-based medicine?. Journal of Evaluation in Clinical Practice 2012, 18:992-999.
2. Ayer A.J. Two notes on probability. The concept of a person and other essays 1963, 188-208. Macmillan.
3. Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., et al. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366:1267-1278. Collaborators, C. T. T.
4. Bajcar J.M., Wang L., Moineddin R., Nie J.X., Tracy C., Upshur R.E.G. From pharmaco-therapy to pharmaco-prevention: Trends in prescribing to older adults in Ontario, Canada, 1997-2006. BMC Family Practice 2010, 11:75.
5. Black D. The limitations of evidence. Perspectives in Biology and Medicine 1998, 42:1-7.
6. Bluhm R., Borgerson K. Evidence-based medicine. Philosophy of medicine 2011, Vol. 16:203-238. Elsevier, Amsterdam. D.M. Gabbay, P. Thagard, J. Woods (Eds.).
7. Broadbent A. Philosophy of epidemiology 2013, Palgrave Macmillan, Basingstoke.
8. Campbell-Scherer D. Multimorbidity: A challenge for evidence-based medicine. Evidence-based Medicine 2010, 15:165-166.
9. Carnap R. On inductive logic. Philosophy of Science 1945, 12:72-97.
10. Cartwright N. Are RCTs the gold standard?. BioSocieties 2007, 2:11-20.
11. Cartwright N. What are randomised controlled trials good for?. Philosophical Studies 2010, 147:59-70.
12. Cartwright N. Predicting 'It will work for us': (Way) beyond statistics. Causality in the sciences 2011, Oxford Scholarship Online. F.R. Phyllis McKay Illari, J. Williamson (Eds.).
13. Cartwright N. Will this policy work for you? Predicting effectiveness better: How philosophy helps. Philosophy of Science 2012, 79:973-989.
14. Clarke B., Gillies D., Illari P.M., Russo F., Williamson J. Mechanisms and the evidence hierarchy. Topoi 2014, 33:339-360.
15. Cowan C.D., Wittes J. Intercept studies, clinical trials, and cluster experiments: To whom can we extrapolate?. Controlled Clinical Trials 1994, 15:24-29.
16. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., et al. General cardiovascular risk profile for use in primary care - The Framingham Heart Study. Circulation 2008, 117:743-753.
17. Dans A.L., Dans L.F., Guyatt G.H., Richardson S. Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA 1998, 279:545-549.
18. Dekkers O.M., von Elm E., Algra A., Romijn J.A., Vandenbroucke J.P. How to assess the external validity of therapeutic trials: A conceptual approach. International Journal of Epidemiology 2010, 39:89-94.
19. Djulbegovic B., Guyatt G.H., Ashcroft R.E. Epistemologic inquiries in evidence-based medicine. Cancer Control 2009, 16:158-216.
20. Djulbegovic B., Hozo I., Greenland S. Uncertainty in clinical medicine. Philosophy of medicine 2011, Vol. 16:299-356. Elsevier, Amsterdam. D.M. Gabbay, P. Thagard, J. Woods (Eds.).
21. Duffin J. History of medicine: A scandalously short introduction 2010, University of Toronto Press, Toronto.
22. EBM Working Group Evidence-based medicine: A new approach to teaching the practice of medicine. Journal of the American Medical Association 1992, 268:2420-2425.
23. Feinstein A.R., Horwitz R.I. Problems in the "evidence" of "evidence-based medicine". American Journal of Medicine 1997, 103:529-535.
24. Flores L.J. Therapeutic inferences for individual patients. Journal of Evaluation in Clinical Practice 2015, 21:440-447.
25. Fuller J. Rhetoric and argumentation: How clinical practice guidelines think. Journal of Evaluation in Clinical Practice 2013, 19:433-441.
26. Fuller J. Rationality and the generalization of randomized controlled trial evidence. Journal of Evaluation in Clinical Practice 2013, 19:644-647.
27. Fuller J., Sankar A., Upshur R.E.G. Concepts in evidence-informed medical practice. The essentials of clinical examination handbook 2013, 571-583. Thieme, Toronto. 7th ed. J. Hall, K. Piggott, M. Vojvodic, K. Zaslavsky (Eds.).
28. Genest J., McPherson R., Frohlich J., Anderson T., Campbell N., Carpentier A., et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Canadian Journal of Cardiology 2009, 25:567-579.
29. Gillies D. Philosophical theories of probability 2000, Routledge, London, New York.
30. Gillies D. Hempelian and Kuhnian approaches in the philosophy of medicine: The Semmelweis case. Studies in History and Philosophy of Biological and Biomedical Sciences 2005, 36:159-181.
31. Glasziou P.P., Irwig L.M. An evidence based approach to individualising treatment. British Medical Journal 1995, 311:1356-1359.
32. Glasziou P., Mant D. Applying results to treatment decisions in primary care. Treating individuals: From randomized trials to personalised medicine 2007, 83-95. The Lancet. P.M. Rothwell (Ed.).
33. Good I.J. On the principle of total evidence. British Journal for the Philosophy of Science 1967, 17:319-321.
34. Goodman S.N. Probability at the bedside: The knowing of chances or the chances of knowing?. Annals of Internal Medicine 1999, 130:604-606.
35. Goulding M.R., Rogers M.E., Smith S.M. Public health and aging: Trends in aging - United States and worldwide. Journal of the American Medical Association 2003, 289:1371-1373.
36. Greenhalgh T., Howick J., Maskrey N. Evidence based medicine: A movement in crisis?. BMJ 2014, 348:g3725.
37. Guyatt G., Rennie D., Meade M.O., Cook D.J. Users' guides to the medical literature: Essentials of evidence-based clinical practice 2008, McGraw-Hill Medical, New York. 2nd ed.
38. Hacking I. An introduction to probability and inductive logic 2001, Cambridge University Press, Cambridge.
39. Hankey G.J. Are n-of-1 trials of any practical value to clinicians and researchers?. Treating individuals: From randomized trials to personalised medicine 2007, 231-246. The Lancet. P.M. Rothwell (Ed.).
40. Hempel C.G. Deductive-nomological vs. statistical explanation. Minnesota studies in the philosophy of science 1962, Vol. 3:98-169. Minneapolis.
41. Hempel C.G., Oppenheim P. Studies in the logic of explanation. Philosophy of Science 1948, 15:135-175.
42. Horton R. Common sense and figures: The rhetoric of validity in medicine. Bradford Hill Memorial Lecture 1999. Statistics in Medicine 2000, 19:3149-3164.
43. Howick J. The philosophy of evidence-based medicine 2011, Wiley-Blackwell, Oxford.
44. Howick J. Exposing the vanities-and a qualified defense-of mechanistic reasoning in health care decision making. Philosophy of Science 2011, 78:926-940.
45. Keynes J.M. A treatise on probability 1921, Macmillan.
46. Kravitz R.L., Duan N., Braslow J. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Quarterly 2004, 82:661-687.
47. Mathers C.D., Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PloS Medicine 2006, 3:e442.
48. Papaioannou A., Morin S., Cheung A.M., Atkinson S., Brown J.P., Feldman S., et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: Summary. Canadian Medical Association Journal 2010, 182:1864-1873.
49. Peltzman S. An evaluation of consumer protection legislation: The 1962 drug amendments. Journal of Political Economy 1973, 81:1049-1091.
50. Post P.N., de Beer H., Guyatt G.H. How to generalize efficacy results of randomized trials: Recommendations based on a systematic review of possible approaches. Journal of Evaluation in Clinical Practice 2013, 19:638-643.
51. Potter P. Short handbook of hippocratic medicine 1988, Éditions du Sphinx, Quebec.
52. Rabi D.M., Daskalopoulou S.S., Padwal R.S., et al. The 2011 Canadian hypertension education program recommendations for the management of hypertension: Blood pressure measurement, diagnosis, assessment of risk, and therapy. Canadian Journal of Cardiology 2011, 27:415-433.
53. Ramsey F.P. Weight or the value of knowledge. British Journal for the Philosophy of Science 1990, 41:1-4.
54. Rawlins M. De testimonio: On the evidence for decisions about the use of therapeutic interventions. Lancet 2008, 372:2152-2161.
55. Rothwell P.M. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005, 365:82-93.
56. Rothwell P.M. Preface. Treating individuals: From randomized trials to personalised medicine 2007, ix-xii. The Lancet. P.M. Rothwell (Ed.).
57. Rubins H.B. From clinical trials to clinical practice: Generalizing from participant to patient. Controlled Clinical Trials 1994, 15:7-10.
58. Salisbury C., Johnson L., Purdy S., Valderas J.M., Montgomery A.A. Epidemiology and impact of multimorbidity in primary care: A retrospective cohort study. British Journal of General Practice 2011, 61:e12-21.
59. Spirtes P., Glymour C., Scheines R. Causation, prediction, and search 2000, MIT Press, Cambridge, MA. 2nd ed.
60. Steel D.P. Across the boundaries: Extrapolation in biology and social science 2008, Oxford University Press, Oxford.
61. Stegenga J. Is meta-analysis the platinum standard of evidence?. Studies in History and Philosophy of Biological and Biomedical Sciences 2011, 42:497-507.
62. Straus S.E., Glasziou P., Richardson W.S., Haynes R.B. Evidence-based medicine: How to practice and teach it 2011, Churchill-Livingstone, New York. 4th ed.
63. Szklo M., Nieto F.J. Epidemiology: Beyond the basics 2007, Jones and Bartlett Publishers, Boston. 2nd ed.
64. Tanenbaum S.J What physicians know. New England Journal of Medicine 1993, 329:1268-1271.
65. Tonelli M.R. The philosophical limits of evidence-based medicine. Academic Medicine 1998, 73:1234-1240.
66. Upshur R.E.G. Looking for rules in a world of exceptions: Reflections on evidence-based practice. Perspectives in Biology and Medicine 2005, 48:477-489.
67. Upshur R.E.G. Do clinical guidelines still make sense? No. Annals of Family Medicine 2014, 12:202-203.
68. Van Spall H.G.C., Toren A., Kiss A., Fowler R.A. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: A systematic sampling review. Journal of the American Medical Association 2007, 297:1233-1240.
69. WHO Global status report on noncommunicable diseases 2010 2011, World Health Organization, Geneva.
70. Zwarenstein M., Treweek S. What kind of randomized trials do we need?. Journal of Clinical Epidemiology 2009, 62:461-463.